IDiyas

For the Inventor, By the Inventor

Berlin, Germany

Ruth Thieroff-Ekerdt

USPTO Granted Patents = 15

Average Co-Inventor Count = 7.1

ph-index = 7

Forward Citations = 128(Granted Patents)


Company Filing History:

goldMedal14 out of 1,384 
 
Schering Aktiengesellschaft
 patents
silverMedal1 out of 4 
 
Schering Aktiengellschaft
 patents

Years Active: 1992-2007

Loading Chart...
15 patents (USPTO):Explore Patents
1. 7211680 - Vitamin D derivatives with carbo-or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments (2007-05-01),
2. 6642218 - Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments (2003-11-04),
3. 6613920 - Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, process for their production, intermediate products and use for the production of pharmaceutical agents (2003-09-02),
4. 6600058 - Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments (2003-07-29),
5. 6376480 - Vitamin D derivatives with substituents at C-25, process for their production, intermediate products and use for the production of pharmaceutical agents (2002-04-23),
6. 6372731 - Vitamin D derivatives with C-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments (2002-04-16),
7. 5700791 - Vitamin D derivatives modified in the 20-position and pharmaceutical (1997-12-23),
8. 5665716 - 24-homo vitamin D derivatives, process for their production and (1997-09-09),
9. 5663157 - 22-en-25-oxa derivatives in the vitamin D series, process for their (1997-09-02),
10. 5585368 - 20-position modified pharmaceutically active vitamin D series compounds (1996-12-17),
11. 5583125 - 25-Carboxylic acid derivatives in the vitamin D series, process for (1996-12-10),
12. 5532228 - Side-chain homologous vitamin D derivatives, process for their (1996-07-02),
13. 5446035 - 20-methyl-substituted vitamin D derivatives (1995-08-29),
14. 5411949 - 23-oxa-derivatives in the vitamin D series, process for their (1995-05-02),
15. 5089175 - Hydroxyalkane carboxylic acid derivatives and their production (1992-02-18),

Title: Ruth Thieroff-Ekerdt: Innovator in Vitamin D Derivatives

Introduction

Ruth Thieroff-Ekerdt is a prominent inventor based in Berlin, Germany, known for her significant contributions to the field of medicinal chemistry. With a remarkable portfolio of 15 patents, she has been instrumental in advancing therapeutic options for various diseases through her innovative research on vitamin D derivatives.

Latest Patents

Her latest patents include the development of vitamin D derivatives featuring carbo- or heterocyclic substituents at C-25. These compounds, which are formulated to address a range of health issues, are particularly useful in the treatment of hyperproliferative diseases of the skin, tumor disorders, precancerous conditions, autoimmune diseases, and several other medical conditions. The patented process also elaborates on intermediate products and their application in producing medicaments. Specifically, these innovative compounds target various diseases, including but not limited to, diabetes mellitus type II, senile osteoporosis, and inflammatory diseases.

Career Highlights

Thieroff-Ekerdt has built a stellar career at notable organizations, such as Schering Aktiengesellschaft. Her work in these institutions has facilitated the translation of her research into practical medical solutions, making a significant impact in the pharmaceutical sector.

Collaborations

Collaboration has been integral to her success. She has worked alongside esteemed colleagues, including Gerald Kirsch and Andreas Steinmeyer, further enhancing the depth and application of her research. These partnerships have fostered an environment of innovation, allowing for a robust exchange of ideas and expertise.

Conclusion

Ruth Thieroff-Ekerdt stands out as a leading inventor whose advancements in vitamin D derivatives continue to influence the field of medical therapeutics. Her dedication to research and collaboration not only underlines her role as an inventor but also contributes significantly to addressing critical health challenges. Her work underscores the importance of innovation in medicine, paving the way for future discoveries and treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…